Home▸Overactive Bladder & Urinary Incontinence▸Bladder Botox Injection Simulator

🚽 Bladder Botox Injection Simulator

This simulation models the intravesical injection of botulinum toxin type A for refractory urge incontinence. It simulates the duration of effect and potential risks such as urinary retention, helping healthcare providers understand treatment outcomes.

Overactive Bladder & Urinary Incontinence2DModerate60 FPS
bladder-botox-injection-simulator ↗ Open standalone

Cystoscopic Multi-Site Detrusor Injection

Placeholder: a rigid or flexible cystoscope guides a needle to inject the detrusor.

  • 20: Injection sites (placeholder short caption)
  • 100-200U: Dose range (placeholder short caption)
  • ~10 min: Procedure time (placeholder short caption)
  • Local: Anesthesia (placeholder short caption)

Injection technique

Placeholder short sentence describing the injection technique.

SNAP-25 Cleavage and Acetylcholine Release Blockade

Placeholder: toxin light chain cleaves SNAP-25 to stop ACh vesicle fusion.

  • SNAP-25: Target protein (placeholder short caption)
  • 3-7 days: Onset of effect (placeholder short caption)
  • SNARE block: Mechanism (placeholder short caption)
  • Type A: Toxin serotype (placeholder short caption)

Molecular blockade

Placeholder short sentence describing the molecular blockade step.

Reduced Involuntary Detrusor Contraction Frequency

Placeholder: overactive bladder contractions become less frequent and weaker.

  • ~70%: Episode reduction (placeholder short caption)
  • Improved: Continence gain (placeholder short caption)
  • ~1 month: Peak benefit (placeholder short caption)
  • Increased: Bladder capacity (placeholder short caption)

Functional effect

Placeholder short sentence describing the functional effect on contractions.

Effect Duration and Waning Over 6-9 Months

Placeholder: clinical benefit gradually declines as nerve terminals regenerate.

  • 7.5 mo: Median duration (placeholder short caption)
  • 6-9 mo: Range (placeholder short caption)
  • Common: Repeat injections (placeholder short caption)
  • Sprouting: Recovery mechanism (placeholder short caption)

Duration curve

Placeholder short sentence describing the effect duration curve.

Urinary Retention and Self-Catheterization Risk

Placeholder: higher doses raise risk of incomplete emptying needing self-cath.

  • ~6-30%: Retention risk (placeholder short caption)
  • Pre-procedure: Self-cath teaching (placeholder short caption)
  • Higher at 200U: Dose dependence (placeholder short caption)
  • Routine: PVR monitoring (placeholder short caption)

Retention management

Placeholder short sentence describing retention risk management.

Placeholder short callout about self-catheterization counseling.
⚙ Under the hood

This simulation models the intravesical injection of botulinum toxin type A for refractory urge incontinence. It simulates the duration of effect and potential risks such as urinary retention, helping healthcare providers understand treatment outcomes.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)